130 related articles for article (PubMed ID: 8318553)
1. Effect of pravastatin, a HMG CoA reductase inhibitor, on blood lipids and aortic lipidosis in cholesterol-fed White Carneau pigeons.
Hadjiisky P; Hermier D; Truffert J; De Gennes JL; Grosgogeat Y
Biochim Biophys Acta; 1993 Jun; 1181(3):279-86. PubMed ID: 8318553
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
Richter WO; Jacob BG; Schwandt P
Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
[TBL] [Abstract][Full Text] [Related]
3. Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen P; Echevaría-Vázquez D; Petrov V
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
[TBL] [Abstract][Full Text] [Related]
4. Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus.
Umeda F; Watanabe J; Inoue K; Hisatomi A; Mimura K; Yamauchi T; Sako Y; Kunisaki M; Tajiri Y; Nawata H
Endocrinol Jpn; 1992 Feb; 39(1):45-50. PubMed ID: 1535040
[TBL] [Abstract][Full Text] [Related]
5. Statins improve visual field alterations related to hypercholesterolemia.
Alcalá A; Jansen S; Téllez T; Gómez-Huelgas R; Pérez O; Egido J; Farkouh ME
Atherosclerosis; 2010 Apr; 209(2):510-4. PubMed ID: 19892351
[TBL] [Abstract][Full Text] [Related]
6. In vivo clearance of low-density lipoproteins and beta-very-low-density lipoproteins in normal and hypercholesterolemic White Carneau pigeons.
Reagan JW; St Clair RW
Biochim Biophys Acta; 1991 Jan; 1081(2):202-10. PubMed ID: 1998739
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
Takayama M; Matsubara M; Arakawa E; Takada C; Ina Y; Hasegawa K; Yao K
Vascul Pharmacol; 2007 Apr; 46(4):302-8. PubMed ID: 17197250
[TBL] [Abstract][Full Text] [Related]
8. Serum lipids of young Show Racer and White Carneau pigeons fed a semipurified diet with or without cholesterol.
Young F
J Nutr; 1974 Jun; 104(6):719-25. PubMed ID: 4830276
[No Abstract] [Full Text] [Related]
9. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
10. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
11. Pravastatin sodium, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases serum total cholesterol in Japanese White rabbits by two different mechanisms.
Miyazaki A; Koga T
Atherosclerosis; 2002 Jun; 162(2):299-306. PubMed ID: 11996949
[TBL] [Abstract][Full Text] [Related]
12. Pravastatin sodium, an inhibitor of HMG-CoA reductase, decreases HDL cholesterol by transfer of cholesteryl ester from HDL to VLDL in Japanese white rabbits.
Miyazaki A; Koieyama T; Shimada Y; Kikuchi T; Ito K; Kasanuki N; Koga T
J Atheroscler Thromb; 2004; 11(1):22-8. PubMed ID: 15067195
[TBL] [Abstract][Full Text] [Related]
13. The effect of pravastatin on serum cholesterol levels in hypercholesterolemic diabetic rabbits.
Arbeeny CM; Bergquist KE
Biochim Biophys Acta; 1991 Apr; 1096(3):238-44. PubMed ID: 1902119
[TBL] [Abstract][Full Text] [Related]
14. Aortic glycosaminoglycans in genetically selected WC-2 pigeons with increased atherosclerosis susceptibility.
Wagner WD; Nohlgren SR
Arteriosclerosis; 1981; 1(3):192-201. PubMed ID: 7295192
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitors suppress the development and progression of carotid artery intimal-medial thickening in hypercholesterolemic type 2 diabetic patients.
Takahashi T; Ishii N; Itai K; Goto R; Higashi K; Kobori S
J Atheroscler Thromb; 2005; 12(3):149-53. PubMed ID: 16020915
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin.
Muramatsu J; Kobayashi A; Hasegawa N; Yokouchi S
Atherosclerosis; 1997 Apr; 130(1-2):179-82. PubMed ID: 9126662
[TBL] [Abstract][Full Text] [Related]
17. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
Lijnen P; Celis H; Desager JP; Fagard R
J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic study of statin therapy and cholesterol reduction.
Chasman DI; Posada D; Subrahmanyan L; Cook NR; Stanton VP; Ridker PM
JAMA; 2004 Jun; 291(23):2821-7. PubMed ID: 15199031
[TBL] [Abstract][Full Text] [Related]
19. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
20. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia.
Milani M; Cimminiello C; Lorena M; Arpaia G; Soncini M; Bonfardeci G
Biomed Pharmacother; 1996; 50(6-7):269-74. PubMed ID: 8952866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
